PT  - JOURNAL ARTICLE
AU  - José María Martín-Olalla
TI  - A reference for mortality in Spain from 2001 to 2019 records with an accurate estimate of excess deaths during the 2020 spring covid-19 outbreak
AID  - 10.1101/2020.07.22.20159707
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.22.20159707
4099  - http://medrxiv.org/content/early/2020/07/24/2020.07.22.20159707.short
4100  - http://medrxiv.org/content/early/2020/07/24/2020.07.22.20159707.full
AB  - Spanish official records of mortality and population in the 21st century are analyzed to determine the reference value of all cause, all age, all sex per capita death rate in the country.This reference is used to analyze the mortality in 2020, largely influenced by a massive anomaly in spring due to covid–19.The most probable mortality excess from Monday March 2 to Sunday May 24, 2020 — W10 to W21— is 1055(17) deaths per one million population or 49 940(730) total deaths. Standard deviation is 67 deaths per one million population. The excess amounts to 53% relative to the expected number of deaths from 21st century records and yields a z− score z = 16 —extremely high excess, according to EuroMoMo classification scheme. Taking into account nationwide seroprevalence(Pollán et al., 2020) that is an infection fatality rate of 2.1%.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was not funded.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:public information only.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this manuscript come from public records. In addition a tsv file is available at https://personal.us.es/olalla/covid/ESPDeathsPopulation.tsv https://personal.us.es/olalla/covid/ESPDeathsPopulation.tsv